Project Grant R35GM155233

Award Date 9/1/24
Completion Date 6/30/29
Dollars Obligated $384K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Penn State University, PA 16802, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), is focused on developing new reactions and reagents to generate enantioenriched organic compounds. The $422,569 award supports research aimed at the concise synthesis of secondary amines, tertiary amines, and vicinal diamines as single stereoisomers. The proposed methods involve the use of bis(amidine) reagents that form chiral...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,566,752 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The University of Texas at San Antonio (UTSA) to develop switchable organometallic catalysts for enabling iterative, site-selective organic synthesis reactions. The goal is to create catalysts that can be "switched" using different wavelengths of light to selectively activate either C(sp2)-X or C(sp3)-X bonds, facilitating the...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $1,114,113 in funding to the University of North Carolina at Chapel Hill (UNC-CH) to develop reactions that enable molecular rigidification. The goal is to create new methods for accessing rigid small and medium-sized strained rings, as well as techniques to stabilize highly reactive alkylidene units using palladium catalysis. The...
This $1,542,569 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) is funding the development of new copper-catalyzed chemical reactions to enable the efficient and stereoselective synthesis of chiral amine derivatives and ethers, including saturated heterocycles. The research objectives include exploring reactions for propagating chirality, developing new enantioselective syntheses of...
This federal Project Grant award of $358,094 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports research to develop new catalytic transformations for alkene synthesis by exploring the reactivity of organoboron compounds in the presence of transition-metal catalysts. The research aims to address challenges in organic synthesis, such as cross-nucleophile coupling, stereocontrol in highly substituted...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research at Stony Brook University aimed at developing a novel approach to organic synthesis using radical reactions inspired by pyridoxal-5'-phosphate (PLP)-dependent enzymes. The $385,298 grant, awarded on February 1, 2025 with a project period through December 31, 2029, will fund the development of two platforms: 1) a...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $1.17M to the University of Texas at Dallas (UTD) to develop new catalytic stereoselective methods and synthesis logics for the preparation of complex bioactive molecules. The award aims to enable reliable access to meaningful quantities of bioactive natural and unnatural compounds with higher complexity, to support the development of...
The National Institute of General Medical Sciences (NIGMS) awarded a 5-year, $357,056 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Wayne State University, located in Detroit, Michigan. The project aims to address limitations in high-throughput experimentation in organic synthesis by developing innovative materials and macromolecular analogs to expand the capabilities of automated liquid handling platforms. Key efforts include: Developing colloidal...
This Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to develop fluorescence lifetime imaging microscopy (FLIM) methods for studying organic reactions and processes. The $1,039,146 award to the University of California, Irvine will be used to characterize reaction intermediates, understand mechanisms, and create predictive models for sustainable aqueous-organic...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $316,682 to Temple University to develop new designer reagents and methods for accessing high-value carbonyl compounds from acetal-based radical precursors. The research aims to implement acetal radicals as a means to access a diverse array of medicinally relevant molecular platforms, with the goal of rapidly constructing pharmaceutical...

This R35 project grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) will fund research to develop innovative synthetic chemistry methods. The $383,884 award to Pennsylvania State University aims to harness radical-mediated reactions to enable new types of olefin difunctionalizations and stereoselective α-functionalizations of carbonyls. These transformations have significant potential for pharmaceutical synthesis but have faced technical limitations with transition-metal catalysts. The proposed research will create conceptual platforms to promote these reactions and access medicinally valuable molecular motifs. The work is expected to span 5 years, from September 2024 to June 2029.

Generated 6/24/25, 6:04 AM